EKF Diagnostics Holdings Plc - Asset Resilience Ratio
EKF Diagnostics Holdings Plc (EKF) has an Asset Resilience Ratio of -1.58% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how EKF Diagnostics Holdings Plc's Asset Resilience Ratio has changed over time. Check EKF strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down EKF Diagnostics Holdings Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EKF market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX-1.29 Million | -1.58% |
| Total Liquid Assets | GBX-1.29 Million | -1.58% |
Asset Resilience Insights
- Limited Liquidity: EKF Diagnostics Holdings Plc maintains only -1.58% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
EKF Diagnostics Holdings Plc Industry Peers by Asset Resilience Ratio
Compare EKF Diagnostics Holdings Plc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for EKF Diagnostics Holdings Plc (2009–2024)
The table below shows the annual Asset Resilience Ratio data for EKF Diagnostics Holdings Plc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | -1.58% | GBX-1.29 Million ≈ $-156.83 |
GBX81.75 Million ≈ $9.95K |
-1.66pp |
| 2011-12-31 | 0.09% | GBX51.00K ≈ $6.21 |
GBX58.73 Million ≈ $7.15K |
-0.19pp |
| 2010-12-31 | 0.28% | GBX100.00K ≈ $12.17 |
GBX35.98 Million ≈ $4.38K |
-7.12pp |
| 2009-12-31 | 7.39% | GBX473.00K ≈ $57.55 |
GBX6.40 Million ≈ $778.33 |
-- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more